Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-23-045168

Options or other derivatives

  • Chief Medical Officer acquired 1,200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ferguson James J. III Chief Medical Officer 2023-12-15 Grant or award · Stock Option (right to Buy) +1,200,000 1,200,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…